Related Experiment Video
Updated: May 6, 2026
10:43
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
Published on: October 31, 2007
28.3K
Transplantation of human islets without immunosuppression
Barbara Ludwig1, Andreas Reichel, Anja Steffen
1Department of Medicine III and Department of Visceral, Thorax, and Vascular Surgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, D-01307 Dresden, Germany.
Summary
A novel oxygenated chamber system enables pancreatic islet transplantation for type-1 diabetes without immunosuppression. This breakthrough offers potential for broader cell-based therapy applications.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Immunology
Background:
- Pancreatic islet transplantation is a promising treatment for type-1 diabetes.
- Current limitations include the need for immunosuppression and donor organ scarcity.
- These factors restrict the therapy to patients with critical metabolic lability.
Purpose of the Study:
- To develop an immune-isolating chamber for pancreatic islet survival and function without immunosuppression.
- To evaluate the efficacy of this novel chamber system in a type-1 diabetes patient.
Main Methods:
- Development of an oxygenated chamber system using immune-isolating alginate and polymembrane covers.
- Transplantation of the chamber into a patient with type-1 diabetes.
- Monitoring of graft function, insulin secretion, and islet morphology for 10 months.
Main Results:
- The transplanted chamber demonstrated persistent graft function for 10 months.
- Regulated insulin secretion was observed.
- Islet morphology and function were preserved without immunosuppressive therapy.
Conclusions:
- The developed oxygenated chamber system successfully supports pancreatic islet survival and function without immunosuppression.
- This approach shows potential for overcoming major hurdles in islet transplantation.
- It may pave the way for wider application of cell-based therapies in treating type-1 diabetes.
